As reported by Xu et al., miR-135b is involved in MMBD impairing the osteogenic differentiation capability of BM-derived MSCs from MM patients (MM-hMSCs) by targeting at 3′ UTR SMAD5, which is involved in osteogenesis. This evidence concerns the gene SMAD5 and Miyoshi myopathy.